Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort

Marissa Zwan; Argonde van Harten; Rik Ossenkoppele; Femke Bouwman; Charlotte Teunissen; Sofie Adriaanse; Adriaan Lammertsma; Philip Scheltens; Bart van Berckel; Wiesje van der Flier

doi:10.3233/JAD-132561

Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort

Marissa Zwan
, Argonde van Harten
, Rik Ossenkoppele
, Femke Bouwman
, Charlotte Teunissen
, Sofie Adriaanse
, Adriaan Lammertsma
, Philip Scheltens
, Bart van Berckel
, Wiesje van der Flier

Amsterdam UMC - Vrije Universiteit Amsterdam

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

BACKGROUND: Two approaches are available for measuring Alzheimer's disease (AD) pathology in vivo. Biomarkers in cerebrospinal fluid (CSF) include amyloid-β1-42 (Aβ42) and tau. Furthermore, amyloid deposition can be visualized using positron emission tomography (PET) and [11C]Pittsburgh compound-B ([11C]PIB).

Original language	English
Pages (from-to)	801-807
Journal	Journal of Alzheimer s disease
Volume	41
Issue number	3
DOIs	https://doi.org/10.3233/JAD-132561
Publication status	Published - 2014

Access to Document

10.3233/JAD-132561

Cite this

@article{468683a256cd46f199a622ac924e2eb6,

title = "Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort",

abstract = "BACKGROUND: Two approaches are available for measuring Alzheimer's disease (AD) pathology in vivo. Biomarkers in cerebrospinal fluid (CSF) include amyloid-β1-42 (Aβ42) and tau. Furthermore, amyloid deposition can be visualized using positron emission tomography (PET) and [11C]Pittsburgh compound-B ([11C]PIB).",

author = "Marissa Zwan and \{van Harten\}, Argonde and Rik Ossenkoppele and Femke Bouwman and Charlotte Teunissen and Sofie Adriaanse and Adriaan Lammertsma and Philip Scheltens and \{van Berckel\}, Bart and \{van der Flier\}, Wiesje",

year = "2014",

doi = "10.3233/JAD-132561",

language = "English",

volume = "41",

pages = "801--807",

journal = "Journal of Alzheimer s disease",

issn = "1387-2877",

publisher = "IOS Press",

number = "3",

}

TY - JOUR

T1 - Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort

AU - Zwan, Marissa

AU - van Harten, Argonde

AU - Ossenkoppele, Rik

AU - Bouwman, Femke

AU - Teunissen, Charlotte

AU - Adriaanse, Sofie

AU - Lammertsma, Adriaan

AU - Scheltens, Philip

AU - van Berckel, Bart

AU - van der Flier, Wiesje

PY - 2014

Y1 - 2014

N2 - BACKGROUND: Two approaches are available for measuring Alzheimer's disease (AD) pathology in vivo. Biomarkers in cerebrospinal fluid (CSF) include amyloid-β1-42 (Aβ42) and tau. Furthermore, amyloid deposition can be visualized using positron emission tomography (PET) and [11C]Pittsburgh compound-B ([11C]PIB).

AB - BACKGROUND: Two approaches are available for measuring Alzheimer's disease (AD) pathology in vivo. Biomarkers in cerebrospinal fluid (CSF) include amyloid-β1-42 (Aβ42) and tau. Furthermore, amyloid deposition can be visualized using positron emission tomography (PET) and [11C]Pittsburgh compound-B ([11C]PIB).

UR - https://www.scopus.com/pages/publications/84925882292

UR - https://www.ncbi.nlm.nih.gov/pubmed/24705549

U2 - 10.3233/JAD-132561

DO - 10.3233/JAD-132561

M3 - Article

C2 - 24705549

SN - 1387-2877

VL - 41

SP - 801

EP - 807

JO - Journal of Alzheimer s disease

JF - Journal of Alzheimer s disease

IS - 3

ER -

Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort

Abstract

Access to Document

Other files and links

Fingerprint

Cite this